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The Cys-loop ligand-gated ion channel family includes the GABA-, glycine-,
serotonin-, and nicotinergic acetylcholine receptors, which all play important
roles in the nervous signal transduction pathway. They are critical targets for
e.g. general anesthetics and alcohol, and all consist of five subunits organized
around a central pore. Here, we investigate the prokaryotic Gloeobacter viola-
ceus pentameric ligand-gated ion channel (GLIC) that is a homolog to the cys-
loop superfamily. GLIC has the advantage of having several X-ray structures
published, and we have previously used it for several different modeling
studies. To better understand the relation between gating and the pore proper-
ties if ligand-gated channels in general, we have substituted several amino res-
idues involved in the kinetics of open and closing of the channel, at different
pH. We have characterized these substitutions using an in vitro electrophysio-
logical functional assay (proton concentration response curves); expressing the
substituted channels in Xenopus laevis oocytes for two-electrode voltage clamp
experiments. We have also made single-channel recordings for investigating
the kinetics (open, closing, and flickering behavior) of the substitutions,
observed in silico. Our results indicate that the hydrophobicity of the pore is
critical to determine both the balance and kinetics of the opening/closing pro-
cess, and it is possible to alter the gating properties of the channel while still
keeping it functional. This is an important step in the process of developing
more effective anesthetics, with a better therapeutic window, but also to iden-
tify a possible molecular mechanism of how to reduce alcohol dependency.
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The prokaryotic Gloeobacter violaceus pentameric ligand-gated ion channel
(GLIC) is an important template for studies of Cys-loop receptors in the human
central nervous system. It is also a key model system to understand the transi-
tions and stabilization of different conformations of membrane proteins
through allosteric modulation - a ligand that opens the channel can either sta-
bilize the open state, or destabilize the closed one. Capturing these processes on
the molecular level will not only enable us to understand gating, but also make
it possible to predict functional responses rather than merely binding properties.
Over the last years, we have studied mutants of the GLIC channel that make it
more similar to the human Cys-loop receptors both experimentally and in sim-
ulations, and shown how this provides evidence for a dual allosteric modulation
mechanism with separate inhibitory and potentiating binding sites. Here, I will
present our new results on mutations in the central GLIC pore. By modifying
the hydrophobicity of one or several residues in the pore it is possible to alter
the pore hydration level, which in turn has paramount effects on the conforma-
tion - molecular simulations show that it is possible to stabilize the channel
either in the open or closed conformation independent of pH. By using
ensemble molecular dynamics simulations covering several tens of microsec-
onds, we show that it is possible to reversibly simulate transitions between con-
formations that are shown to actually conduct ions or block the current in
simulations. In vivo electrophysiology and single-channel recordings on the
mutants confirm this influence on the kinetics, and provide us with a way to
couple molecular-level dynamics and kinetics to the experimentally observed
equilibrium and transitions between conformations.
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Institut Pasteur, Paris, France.Pentameric ligand-gated ion channels (pLGIC) mediate fast chemical trans-
mission of nerve signals. The structure of GLIC, a bacterial proton-gated ho-
molog, has been established in its open and Locally Closed (LC)
conformations at acidic pH. Here we report a new crystal form where the
LC and open conformations coexist as discrete forms at acidic pH. These re-
sults, together with site-directed mutagenesis and physiological recordings,
shed new light on the allosteric transitions of pLGIC and their
pharmacology.Cardiac Muscle I
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The DK210 mutation in cardiac troponin T causes dilated cardiomyopathy
(DCM) in human by impairing cardiac systolic function through a decrease
in cardiac myofilament Ca2þ sensitivity. Knock-in mice on the BALB/c back-
ground exhibit progressive heart failure (HF), leading to premature death. In
this study, effects of Ca2þ sensitizer pimobendan on HF were examined using
this DCM model. Pimobendan was administered orally once daily at two
doses,10 (low dose) and 100 (high dose) mg/kg, at two different stages, 4
weeks old with ejection fraction (EF) of over 35% (compensated stage) and
6-9 weeks old with EF of less than 35% (end-stage). Pimobendan improved
life-expectancy at both stages, with a similar effect at low dose. High dose
pimobendan further improved it at compensated stage, but had a much less
effect than low dose at end-stage due to frequent sudden death. Pimobendan
prevented the increase in heart and lung weight in a dose-dependent manner
at compensated stage with the increase being almost completely blocked at
high dose, whereas it had no effects at end-stage at any dose. Only high
dose pimobendan improved HF symptoms such as dyspnea at end-stage
and prevented their development at compensated stage. These results suggest
that a high dose pimobendan might have beneficial effects to improve life ex-
pectancy at compensated stage by preventing the development of HF, but it
may conversely impair life-expectancy at end-stage HF by increasing the
risk of sudden death. On the other hand, a low dose pimobendan might
improve life-expectancy at end-stage HF, although it could not prevent HF
even at compensated stage. To clarify the mechanisms by which optimal
doses of pimobendan are different in compensated and end-stage HF, inves-
tigation of the effect of pimobendan on isolated cardiomyocytes is in
progress.
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After chronic myocardial infarction (CMI) the myocardium undergoes remod-
eling which is described initially as ‘hypertrophic’ followed by ‘de-compensa-
tion’. We have studied this phenomenon at the sarcomeric level to understand
how muscle mechanics, post-translational modifications, tissue morphology
and sarcomeric structures are affected in the remaining well-perfused tissue.
We use a rat model of left anterior descending (LAD) ligation to create pheno-
typic chronic myocardial infarction (CMI). A specialized temperature jump
(T-jump) approach assess changes to myocardial muscle function during phys-
iological shortening in saturating (32mM) and physiological (1mM) calcium
concentrations. During ‘compensation’ we observe higher power (45%)
compared to control. During ‘de-compensation’ we observe a 50% reduction
in peak power and 40% reduction in maximal unloaded shortening velocity
(Vmax). We exploit second harmonic generation (SHG) by two-photon excita-
tion microscopy (TPE) to assess collagen abundance and infiltration. Global
type I collagen abundance and infiltration increases 2-fold post-AMI but
does not change during disease progression. Phos-Tag SDS-PAGE is used to
assess Troponin I (TnI), Myosin Binding Protein C (MyBP-C) and Regulatory
Light Chain (RLC) phosphorylation. Electron microscopy is used to assess sar-
comeric organization and mitochondrial health and abundance. Sarcomeric
disorder becomes evident with disease progression as well as a global reduc-
tion in functional mitochondria. This study demonstrates that sarcomeric pro-
tein modification is an important modifier of cardiac muscle function during
